About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 431 record(s)
Req # A-2021-000515
In January 2021, interviews were conducted with NGOs and Health Care Providers as part of "an evaluation of Health Portfolio Tobacco and Vaping Activities, which includes both Health Canada and the Public Health Agency of Canada". A copy of the following documents: The final evaluation report (if it is ready) or the most recent draft copy. Any documents used in the design of the questionnaire to identify the short and medium term outcome "increasing awareness of vaping as a smoking cessation tool that is less harmful than tobacco."Organization: Health Canada
August 2021
Req # A-2021-000544
Adverse Reaction Reports (AERs) for LEUPROLIDE ACETATE. Report numbers: E2B_03413381, E2B_03413387, 000926931.Organization: Health Canada
August 2021
Req # A-2021-000545
Adverse Drug Reaction (ADR) for ALIROCUMAB. Report number: E2B_03408783.Organization: Health Canada
August 2021
Req # A-2021-000550
Adverse Drug Reaction (ADR) for METOLAZONE. Report number: 000922329.Organization: Health Canada
August 2021
Req # A-2021-000553
Adverse Reaction Reports (AERs) for SARILUMAB. Report numbers: E2B_03481113, E2B_03326624.Organization: Health Canada
August 2021
Req # A-2021-000574
Adverse Drug Reaction (ADR). Report number: 000941781.Organization: Health Canada
August 2021
Req # A-2021-000577
Adverse Drug Reaction (ADR). Report number: 000947871.Organization: Health Canada
August 2021
Req # A-2021-000578
Adverse Drug Reaction (ADR). Report number: 000948466.Organization: Health Canada
August 2021
Req # A-2021-000606
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-075471-867.Organization: Health Canada
August 2021
Req # A-2021-000610
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-115518-128.Organization: Health Canada
August 2021